chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Projectile vomiting for days. Went away within a week. Right before he turned 1 month old, he developed eczema. Right before he turned 3 months old, he started to throw up after every time I breast fed him. I spent weeks doing elimination diets. At 4 months old, I figured out he was allergic to wheat, dairy, eggs, peanuts, and tree nuts. We had his blood tested by an allergist. He was allergic to wheat, dairy, eggs, peanuts, tree nuts, soy, corn, and dogs. By 5 months old, he still wasn't well, he never got clear skin and never stopped puking. I was still breastfeeding and thought he was allergic to banana, coconut, sunflower seeds, oats, flax seeds, and oats. We had blood tests drawn and he was in fact allergic to all of those allergens. I had him tested for protein and veggies, and he tested negative for those. I only ate those, and he developed more allergies to the point we had to put him on Neocate. By 6 months old, he had fallen to the 5th%, was still showing signs of being allergic to something, so we put him on Neocate.
I did not suffer from migraines prior to receiving my second dose of COVID vaccine. After the second vaccine, I developed a migraine headache that persisted over five days. The migraine has returned every month around the time of my menstrual period. I cannot stress enough that I did not experience migraines as a period symptom prior to receiving the second dose. The migraine feels identical to the one I experienced after my second dose and it is quite unique as in it is unlike any other headache I've ever had. It is accompanied my nausea and in the same location in my head.
Pt said her arm was a bit sore after the shot. Next day it spreads from arm to her upper back. Her left arm was weak & sore when she coughs, she had a little difficult breathing. I repeatedly asked her to go to dr to check on 7/23/12 7/24/12 called pt & she said she is getting better. Her arm is still sore but not as bad & her back is better. There is a little red rash below the bandage which she didn't remove. I recommended she continues ADVIL for few days. Pt took 7/23/12 per #2 ADVIL & arm 7/24/12
"Sweats thru night of injection "per mother, arm swollen and red deltoid within 24 hours - persisting greater than 48 hours. Using Tylenol/ Motrin - patient declined cold/ hot packs to arm. Positive mobility/normal temp and color of hand and fingers.
Patient was given the two vaccinations above in the left arm on 10/17. She presented to the pharmacy on 10/18 with an injection site reaction that included redness, pain and swelling. Called patient on 10/20 and she stated it was subsiding but still present.
administer expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The expiry date was reported as 09-Nov-2021  Date the vial was initially stored in the refrigerator was unknown.  The vial did not undergo any temperature excursions.  No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up non-significant document received and updated in the narrative
doses administered after excursion; No adverse event; doses administered after excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (doses administered after excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) in a 43-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (doses administered after excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (doses administered after excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion).    No concomitant medications were reported.  Reporter reported that a temperature excursion that occurred several days ago in the Freezer. Reported that Prior to knowing that the vaccine which underwent a temperature excursion in the freezer were viable and patient received dose of the vaccine. The excursion was found out in an audit. The Agent guided the reporter to the online temperature excursion tool and found that vaccines were viable. Patient did not report any adverse reactions.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-675735 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-675735:Master case Same reporter
Headache dizzy, facial numbness, tingling to lip and tongue Narrative:  Headache, dizzy, facial numbness, tingling to lip and tongue; escorted immediately to ER.
She got a brown spot on injection site 9 days after receiving 1st dose; It is very sore and achy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (She got a brown spot on injection site 9 days after receiving 1st dose) and INJECTION SITE PAIN (It is very sore and achy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Diabetes.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced INJECTION SITE DISCOLOURATION (She got a brown spot on injection site 9 days after receiving 1st dose) and INJECTION SITE PAIN (It is very sore and achy). At the time of the report, INJECTION SITE DISCOLOURATION (She got a brown spot on injection site 9 days after receiving 1st dose) and INJECTION SITE PAIN (It is very sore and achy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include unspecified medication for Diabetes (Type not reported) and unspecified medication for high blood pressure.
Pt developed an urticarial rash over his entire body area including scalp, face, back, trunk, buttocks, genitalia, extremities approximately 18 hours after administration of Hepatitis A, MMR, and Varicella vaccines. Received one dose of diphenhydramine in clinic, prescribed hydroxyzine, rash improving.
Patient was admitted on 8/21 with CT proven appendicitis. She underwent laparoscopic appendectomy. She tolerated this well and was seen postoperatively where her pain was well controlled on oral pain medication, ambulating, tolerating a diet and felt comfortable going home.
ModernaCovid-19 Vaccine EUA.  Aweek after recieving vaccine my left arm (shot site)began to itch and the next morning I had a 2.5 inch diameter raised red circle that over the next 4 days ached,itched and slowly spread out .Eventually   the rash went away.All good now
Itchy; Hives on both of her arms; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives on both of her arms) and PRURITUS (Itchy) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced URTICARIA (Hives on both of her arms). On an unknown date, the patient experienced PRURITUS (Itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) ongoing since an unknown date for Itchy, at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives on both of her arms) and PRURITUS (Itchy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. The patient developed hives on both of her arms somewhere around 23-Feb-2021. The physician reported that the patient has no history of prior hives. The patient responded to Benadryl (diphenhydramine hydrochloride), due to the event became itchy and looked like hives.  Treatment medications included unspecified antihistamines which the patient responded well to and diphenhydramine hydrochloride.
Patient received 4 doses of a covid vaccine.  Ill and in ER day after 4th dose where ER MD noticed the error
I noticed that tiny, red blood blisters appeared on my thighs and lower legs on the evening of  2/09/21 (9 days after receiving the vaccine). There was no pain or itching that accompanied  the appearance of this 'rash'. The spots darkened by the next day and were clearly disappearing by the 11th of Feb. No other side effects, other than moderate soreness at the site of the injection and general mild aches and pains within the first 24 hours of receiving the vaccination.  No treatment was sought.
Information has been received from a physician concerning a pt who in Aug 2006, was vaccinated with a first dose of Rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human Bovine). Within 2 days in Aug 2006, the pt developed vomiting. The vomiting resolved within a week. No subsequent doses of Rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human Bovine) had been administered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Pt received J&J COVID vaccination during down time 3/30 approximately 7 minutes after receiving the vaccination at 1:50pm  Patient reported feeling dizzy and having double vision. Pt VS remained stable and instructed Pt to take deep breathes. After a few minutes Pt still was feeling dizzy, instructed patient to lay back and elevate feet while taking deep breathes. Pt still feeling dizzy and faint per protocol administered 15L/min O2. At 2:05 patient started to feel better better and removed O2. Monitored patient for 10 more minutes. Pt stated she felt better and requested to leave. Instructed patient to take deep breaths and report to her doctor if she felt bad again. Patient reported she understood and left with her husband .
2 weeks after getting the vaccine I started to get some balls in my arm, it got red and swollen. My neck was really swollen. That day I decided to go to a clinic because I was scared it might have been a blood clot. They sent me to urgent care since they thought it was a blood clot. They did an ultrasound and they said it was not a blood clot. I went home and 2 days after I got a ball on my arm around the interior part of the elbow. I went to the ER because it was too big and I was afraid it was a blood clot. The doctor asked if I had had the vaccine and I said yes and he said it must have been a reaction to the vaccine. I went home and they called me and told me that I needed to come back to get another ultrasound to see if it was a blood clot. It was not. They did not give me any mediation. They also did blood work. They told me to make an appointment with my primary doctor. She also told me it must have been a bad reaction to the vaccine and that it should go away in about 3 weeks or one month. I still have the same symptoms going on. It's been 3 months since I started having symptoms.
EXPIRED VACCINE ADMINISTERED (VACCINE ADMINISTERED TO 2 MALES FROM AN EXPIRED LOT); .This spontaneous report received from a health care professional concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 19-SEP-2021) dose was not reported, administered on 21-SEP-2021 for prophylactic vaccination. The batch numbers were not reported and have been requested. No concomitant medications were reported. On 21-SEP-2021, the patient experienced expired vaccine administered (vaccine administered to 2 males from an expired lot). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered (vaccine administered to 2 males from an expired lot) was not reported. This report was non-serious. This case, from the same reporter is linked to 20210941889.
When talked with the Mother on 11-7-13 she said the pt had a reaction. That it was red and swollen. No one at facility saw the reaction so we do not know what it looked like.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated (Oka/Merck) VARIVAX dose 1, (dose, lot # and expiry date unknown) On 27-MAY-2011, the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX dose 2, from lot # 0552Z (dose and expiry date unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review of records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provided 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
something happened about 22 days later, 24 days later I came down with the case of PMR; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), administration date 19Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), administration date: 22Mar2021, for COVID-19 Immunization. The following information was reported: POLYMYALGIA RHEUMATICA (medically significant) with onset 2021, outcome "unknown", described as "something happened about 22 days later, 24 days later I came down with the case of PMR". Reporter stated, he just want to inform that he had something that might be related to Pfizer, COVID vaccine. He had two Pfizer vaccines. So, he had those two, his wife and he was just looking at their calendar and something happened about 22 days later, 24 days later he came down with the case of PMR (further not clarified).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient's husband reports that she had difficulty raising her arm after going home from the vaccination.  Patient asked her physician about it and he said it would get better.  Patient says that has subsided but still feels twinges of nerve pain in neck about injection site.
injection site redness; injection site itching; injection site swelling; This is a spontaneous report from a contactable consumer (patient). A 71-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6203), via an unspecified route of administration, administered in Arm Left on 20Feb2021 13:15 (at the age of 71 years old) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient had no known allergies. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN5318), via an unspecified route of administration, administered in Arm Left on 30Jan2021 13:00 (at the age of 70 years old) as a single dose for COVID-19 immunization. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient did not receive any other vaccination in last in four weeks. The patient received other medication in last 2 weeks but not reported. On 21Feb2021 12:00 the patient experienced injection site redness, injection site itching, and injection site swelling. The patient did not receive any treatment for events. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
Dry cough, body aches, chills, decreased PO intake, worsening fatigue. Exposed to unvaccinated family and tested positive for COVID on 7/23. New hypoxia reported on admission (six days of symptoms). Completed two doses of remdesivir (discontinued due to reports of bradycardia) and four doses of dexamethasone during admission.
Rash that covers her whole body, more prominent in hands and feet. Swollen shot area that looks blistery, about 3 inches big..
NauseaVomiting, Angina, shortness of breath, left sided chest pain Narrative:
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 26-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 24Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 26 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster) single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". Therapeutic measures were taken such as Paxlovid as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events drug ineffective and covid-19 with the suspect drugs BNT162B2 and BNT162b2, BNT162b2 omi ba.4-5 cannot be excluded. The case will be reassessed once new information is available.
Provider ordered PPSV23 during patient's visit, but HPV was administered.  Provider immediately assessed patient.  Patient did not report any discomfort or concern. Provider cleared patient and addressed all questions
outbreak of herpes; This case was reported by a consumer via interactive digital media and described the occurrence of herpes virus infection in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2021, the patient received the 1st dose of Shingrix. In August 2021, less than a week after receiving Shingrix, the patient experienced herpes virus infection. On an unknown date, the outcome of the herpes virus infection was not recovered/not resolved.   It was unknown if the reporter considered the herpes virus infection to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received Shingrix vaccine 4 days ago and experienced an outbreak of herpes.
Left neck glands swelled after 3 days; Left leg lower swolled 5 days; Sick for 3 days; 100 degree temp; Numb hands; Legs pin pricks time to time; Weakness; Severe headaches; Sinus pain pressure; Sinus pain pressure; Insomnia; Facial pain; This is a spontaneous report received from a contactable consumer (patient). A 49-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 30Jul2021 at 09:30 (at the age of 49-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included GI issues, ulcer, seasonal allergy, lactose intolerance and known allergies to amoxicillin, penicillin. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications in two weeks prior to the vaccination. Prior to the vaccination, it was unknown the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 02Aug2021 at 12:00, the patient experienced left neck glands swelled after 3 days, left leg lower swelled 5 days, sick for 3 days, 100 degree temp, numb hands and legs pin pricks time to time, weakness, severe headaches and sinus pain pressure, insomnia, facial pain. Patient visited to doctor or other healthcare professional office/clinic visit. Patient received treatment for Head and sinus issues. 2 urgent care visits 1 ER. The outcome of the events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Fever started at 6th day after the shot fallowed by swelling of the face and throat, fast heartbeat, dizziness, weakness. Major behavior changes, tantrums, hurting himself, no contact, no response. Temperature of 102 F on and off everything until 14 days after the vaccine.